Skip to main content

Vanesa Richarte Fernández

-

Institutions of which they are part

Senior researcher
Psychiatry, Mental Health and Addictions
Vall Hebron Institut de Recerca
Psychiatrics
General Hospital

Vanesa Richarte Fernández

Institutions of which they are part

Senior researcher
Psychiatry, Mental Health and Addictions
Vall Hebron Institut de Recerca
Psychiatrics
General Hospital

-

Graduate in Medicine and Surgery from the Universitat Autònoma de Barcelona. Specialist in Psychiatry at the Hospital de la Santa Creu i Sant Pau. PhD in Psychiatry and Clinical Psychology from the Universitat Autònoma de Barcelona (UAB). Master's Degree in Paidopsychiatry (UAB).

Coordinator of the ADHD Programme at Vall de Hebron University Hospital. Associate clinical lecturer at the Universitat Autònoma de Barcelona.
My healthcare work is focused on the assessment, diagnosis and treatment of ADHD and its comorbidities in children, adolescents and adults.

Co-author of more than 50 national and international publications on ADHD, with an h=25 index and 5 book chapters. Member of the Vall Hebron Research Institute, research focused on childhood, adolescent and adult ADHD, including clinical trials on pharmacological and psychological treatments, neuroimaging, genetics and intestinal microbiome studies.

Projects

Identificación de factores de riesgo en el Trastorno por Déficit de Atención con Hiperactividad (TDAH) a través del estudio del perfil de metilación de ADN a escala genómica

IP: Marta Ribases Haro
Collaborators: Montserrat Corrales De la Cruz, Iris Garcia Martínez, Vanesa Richarte Fernández
Funding agency: Instituto de Salud Carlos III
Funding: 122815
Reference: PI14/01700
Duration: 01/01/2015 - 31/12/2018

Psiquiatria, Salut Mental i Addicions (GRC)

IP: Miquel Casas Brugué
Collaborators: Núria Gómez Barros, Natalia Calvo Piñero, Montserrat Corrales De la Cruz, Marc Ferrer Vinardell, José Antonio Ramos Quiroga, Lara Grau Lopez, Iris Garcia Martínez, Marta Ribases Haro, Raquel Vidal Estrada, Vanesa Richarte Fernández, Francisco Collazos Sanchez
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 27000
Reference: 2014 SGR 1357
Duration: 01/01/2014 - 31/12/2016

Relación entre los antecedentes de prematuridad y el consumo de fármacos para el tratamiento del TDAH en la infancia. Estudio observacional retrospectivo.

IP: Josep Perapoch López
Collaborators: Alfons Macaya Ruíz, Vanesa Richarte Fernández
Funding agency: Fundación Alicia Koplowitz
Funding: 50000
Reference: FAK-2012-02
Duration: 01/10/2012 - 30/12/2014

Estudio multimodal sobre la influencia en la estructura y función cerebral del gen Latrofilina 3 (LPHN3) en adultos con Trastorno por Déficit de Atención con Hiperactividad

IP: Miquel Casas Brugué
Collaborators: Marc Ferrer Vinardell, Vanesa Richarte Fernández
Funding agency: Instituto de Salud Carlos III
Funding: 125235
Reference: PI11/01629
Duration: 01/01/2012 - 30/09/2015

Related news

Irritability in ADHD and BDP is an understudied symptom that has a major impact on patients' quality of life and may even increase the risk of suicide.

These results reinforce the need for more individualized attention to address educational needs from an early stage.

On World Clinical Trials Day, we highlight some of the studies we have participated in that confirm the efficacy of new drugs, allowing their approval by regulatory agencies.

Related professionals

Santos Ortega, Alba

Santos Ortega, Alba

Predoctoral researcher
Cardiovascular Diseases
Read more
Xavier Cañas Perea

Xavier Cañas Perea

Director/a d'Àrea
Clinical Research Development Directorate
Read more
Ruiz Esteve, Fernando

Ruiz Esteve, Fernando

Research technician
Neurovascular Diseases
Read more
Marcos Prieto, Susana

Marcos Prieto, Susana

Research technician
Molecular Medical Imaging
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.